CIK 0000879169 · Large accelerated filer
INCYTE CORP
Sign in to watch- Ticker
- INCY
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943136539
- Phone
- 3024986700
- Business address
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
- Former names
- INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $32,959,897
- in 5 filings, $33.0M under 10b5-1 plans
Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-19 | CAGNONI PABLO J President, R&D | Option exercise 10b5-1 | +5,575 | $61.18 | $341K | 253,468 |
| 2026-02-19 | CAGNONI PABLO J President, R&D | Sale 10b5-1 | −18,668 | $100.91 | $1.9M | 234,800 |
| 2026-02-19 | CAGNONI PABLO J President, R&D | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −13,093 | 7,182 | ||
| 2026-02-19 | CAGNONI PABLO J President, R&D | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,575 | 16,268 | ||
| 2026-02-02 | Heeson Lee EVP, Head of Incyte Intl | Shares withheld for taxes | −111 | $102.67 | $11K | 38,041 |
| 2026-02-02 | Morrissey Michael James EVP, Head of Tech. Operations | Shares withheld for taxes | −185 | $102.67 | $19K | 34,065 |
| 2026-01-20 | Morrissey Michael James EVP, Head of Tech. Operations | Shares withheld for taxes | −429 | $102.62 | $44K | 34,250 |
| 2026-01-16 | Mayes Patrick A EVP & Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +4,218 | 4,218 | ||
| 2026-01-16 | Issa Mohamed Khairie EVP, Head of US Oncology | Grant or award · Employee Stock Option (right to buy) | +14,237 | 14,237 | ||
| 2026-01-16 | Heeson Lee EVP, Head of Incyte Intl | Grant or award | +8,911 | 38,152 | ||
| 2026-01-16 | Trotta Matteo EVP, GM, Dermatology US | Grant or award · Employee Stock Option (right to buy) | +8,542 | 8,542 | ||
| 2026-01-16 | Tray Thomas Principal Accounting Officer | Grant or award · Employee Stock Option (right to buy) | +2,425 | 2,425 | ||
| 2026-01-16 | Morrissey Michael James EVP, Head of Tech. Operations | Grant or award | +7,426 | 34,679 | ||
| 2026-01-16 | Stein Steven H EVP & Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +19,932 | 19,932 | ||
| 2026-01-16 | CAGNONI PABLO J President, R&D | Grant or award · Employee Stock Option (right to buy) | +28,475 | 28,475 | ||
| 2026-01-07 | Issa Mohamed Khairie EVP, Head of US Oncology | Sale 10b5-1 | −10,856 | $109.07 | $1.2M | 66,132 |
| 2026-01-06 | Issa Mohamed Khairie EVP, Head of US Oncology | Shares withheld for taxes 10b5-1 | −8,264 | $106.66 | $881K | 76,988 |
| 2026-01-05 | Stein Steven H EVP & Chief Medical Officer | Sale 10b5-1 | −15,634 | $101.70 | $1.6M | 34,203 |
| 2025-12-31 | Morrissey Michael James EVP, Head of Tech. Operations | Shares withheld for taxes | −254 | $98.77 | $25K | 27,253 |
| 2025-12-31 | Stein Steven H EVP & Chief Medical Officer | Shares withheld for taxes | −13,292 | $98.77 | $1.3M | 49,837 |
Page 12 of 15 · 293 trades